300 North Capital’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

300 North Capital’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$251K	Sell	5,610 -74,459	-93%	-$2.8M	1.54%	35
2015 Q1	$2.77M	Buy	+80,069	New	+$2.18M	0.61%	68

Other funds holding DPLO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

300 North Capital's DPLO Position: Q2 2015 in Review

300 North Capital reduced its DIPLOMAT PHARMACY, INC. (DPLO) stake by 93% in Q2 2015, selling an estimated $2.8M and leaving 5,610 shares worth $251K. The position accounts for 1.54% of the portfolio, ranked #35.

300 North Capital first reported a position in DPLO in Q1 2015 and has held it in 2 quarters since. The position peaked at $2.77M in Q1 2015. 126 funds tracked by Wall St. Rank hold DPLO as of Q2 2015.

300 North Capital held 5,610 shares of DIPLOMAT PHARMACY, INC. worth $251K as of Q2 2015.
300 North Capital sold 74,459 DIPLOMAT PHARMACY, INC. shares in Q2 2015, an estimated $2.8M.
DIPLOMAT PHARMACY, INC. made up 1.54% of 300 North Capital's portfolio in Q2 2015, its #35 holding.
300 North Capital first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and has held it in 2 quarters since.
300 North Capital's DIPLOMAT PHARMACY, INC. position peaked at $2.77M in Q1 2015.
126 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2015.

Based on 300 North Capital's 13F filing for Q2 2015, filed 30 Jul 2015.